CytomX Therapeutics Inc (NAS:CTMX)
$ 1.2 0 (0%) Market Cap: 93.74 Mil Enterprise Value: -31.70 Mil PE Ratio: 8.57 PB Ratio: 0 GF Score: 55/100

Q4 2021 CytomX Therapeutics Inc Earnings Call Transcript

Mar 01, 2022 / 10:00PM GMT
Release Date Price: $3.54 (-7.57%)
Operator

Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter and Full Year 2021 Financial Results Call. Please be advised that today's call is being recorded.

I would now like to hand the call over to your host today, Chau Cheng, CytomX's Vice President, Investor Relations and Corporate Communications. Please go ahead.

Chau Cheng
CytomX Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Michelle. Good afternoon, and thank you for joining us. With me today are Dr. Sean McCarthy, CytomX' Chief Executive Officer and Chairman; Dr. Amy Peterson, President and Chief Operating Officer; and Chris Ogden, Vice President, Finance and Accounting.

Earlier today, we issued a press release that includes a summary of our fourth quarter and full year 2021 financial results and highlights the important progress we made during the year. We encourage everyone to read today's press release and the associated materials, which have been filed with the SEC. Additionally, the press release and recording

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot